title: Myelitis due to enterovirus in patient on interferon therapy for chronic hepatitis B: case report.
authors.forename: Marina
authors.initials: M
authors.lastname: Polidori
authors.forename: Enrico
authors.initials: E
authors.lastname: Tagliaferri
authors.forename: Carlo
authors.initials: C
authors.lastname: Tascini
authors.forename: Giovanni
authors.initials: G
authors.lastname: Andreotti
authors.forename: Sarah
authors.initials: S
authors.lastname: Flammini
authors.forename: Francesco
authors.initials: F
authors.lastname: Menichetti
mesh_terms: D000005:Abdomen / Q000473:pathology; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D004279:DNA, Viral / Q000134:cerebrospinal fluid; D004769:Enterovirus Infections / Q000097:blood / Q000134:cerebrospinal fluid / Q000150:complications* / Q000188:drug therapy; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D035002:Lower Extremity / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009187:Myelitis / Q000097:blood / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000821:virology*; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins; D013116:Spinal Cord / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a